BSE - Delayed Quote INR

Nippon India Pharma Bns (0P00005UQE.BO)

496.97
+0.38
+(0.08%)
At close: May 1 at 1:30:00 AM GMT+5:30

Top 10 Holdings (61.02% of Total Assets)

SymbolCompany% Assets
Sun Pharmaceutical Industries Limited 13.68%
Divi's Laboratories Limited 9.32%
Lupin Limited 7.73%
Cipla Limited 5.90%
Dr. Reddy's Laboratories Limited 5.35%
Apollo Hospitals Enterprise Limited 5.14%
Abbott India Limited 3.82%
Vijaya Diagnostic Centre Limited 3.41%
MedPlus Health Services Limited 3.39%
GlaxoSmithKline Pharmaceuticals Limited 3.28%

Sector Weightings

Sector0P00005UQE.BO
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 1.11%
Stocks 98.89%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average 0P00005UQE.BO Category Average
Price/Earnings 0.03 --
Price/Book 0.17 --
Price/Sales 0.2 --
Price/Cashflow 0.03 --
Median Market Cap 597,934.94 --
3 Year Earnings Growth 21.34 --

Bond Holdings

Performance & Risk

YTD Return -5.71%
5y Average Return 22.57%
Rank in Category (ytd) 15
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.91
Morningstar Risk Rating --

Fund Overview

Category --
Fund Family Nippon Life India Asset Management Ltd
Net Assets 1.28B
YTD Return -14.28%
Yield 0.00%
Morningstar Rating --
Inception Date Jun 05, 2004

Fund Summary

Related Tickers